Loading company…
TJ Biopharma researches, develops and manufactures biopharmaceutical products across several disease areas.
TJ Biopharma develops and sells biopharmaceuticals for diabetes, tumors, autoimmune diseases and other conditions. It has R&D bases in Shanghai and Beijing and manufacturing facilities in Hangzhou. The company is based in Hangzhou, China, and was formed from I-Mab's China business and assets. In September 2025, it raised approximately CNY 600.00 million in Series C2 funding led by CICC Capital and other investors to advance Phase III trials, regulatory approvals and drug candidates.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in